Human Epilepsy Project 2: Resistant Focal Seizures Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brandy Fureman, PhD
Epilepsy Foundation
Principal Investigator - Daniel Lowenstein, MD
University of California, San Francisco
Principal Investigator - Jacqueline French, MD
New York University
Principal Investigator - Ruben Kuzniecky, MD
Northwell Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Francisco
San Francisco, California, United States
- Yale Comprehensive Epilepsy Center
New Haven, Connecticut, United States
- University of Miami
Miami, Florida, United States
- Idaho Comprehensive Epilepsy Center
Boise, Idaho, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Minnesota Epilepsy Group
Saint Paul, Minnesota, United States
- New York University
New York, New York, United States
- Northwell Health Comprehensive Epilepsy Center
New York, New York, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt Epilepsy Center
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2018
- Primary completion
- 30 Jul 2022
- Completion
- 30 Sept 2022
- Last update posted
- 18 Sept 2023
- Registered enrollment
- 157
- Registry id
- NCT03531008
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.